Page last updated: 2024-10-22

amlodipine and Hypoparathyroidism

amlodipine has been researched along with Hypoparathyroidism in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolanthakodi, N1
Vidyasagar, S1
Varma, M1
Holla, A1

Other Studies

1 other study available for amlodipine and Hypoparathyroidism

ArticleYear
Posterior reversible encephalopathy syndrome due to hypercalcaemia: a rare cause.
    BMJ case reports, 2019, Feb-11, Volume: 12, Issue:2

    Topics: Amlodipine; Calcium, Dietary; Dietary Supplements; Female; Fluid Therapy; Humans; Hypercalcemia; Hyp

2019